Skip to main content

Advertisement

We're creating a new version of this page. See preview

  • Correction
  • Open Access

Correction to: Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history

Translational Neurodegeneration20198:10

https://doi.org/10.1186/s40035-019-0150-3

  • Published:

The original article was published in Translational Neurodegeneration 2019 8:2

Correction to: Transl Neurodegener (2019) 8:2

https://doi.org/10.1186/s40035-018-0142-8

In the original publication of this article [1], a numerical value in the sentence “The mean (SD) AAO was 43.92 years (9.24) for all subjects, with a significant difference between patients carrying mutations in exon 2 (n = 24, 46.83, 8.31) and exon 4 (n = 18, 37.75, 7.67) (p = 0.002).” is wrong. The true value in the parenthesis of exon 2 should be (n = 24, 46.63, 8.31).

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Neurology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, People’s Republic of China

Reference

  1. Tang L, et al. Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history. Transl Neurodegener. 2019;8:2 https://doi.org/10.1186/s40035-018-0142-8.View ArticleGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement